Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Avatar

Chemotherapy vs. Chemo Free in Indolent Non-Hodgkin Lymphoma - Can We Improve Outcomes With Emerging Agents?

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Nathan H. Fowler
October 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Moffitt Cancer Center

16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

Sat, Jan 18, 2020
8th ESO-SIOP Europe Masterclass in Paediatric Oncology

8th ESO-SIOP Europe Masterclass in Paediatric Oncology

Sat, Jun 6, 2020
Indy Hematology Review

17th Indy Hematology Review

Sat, Mar 21, 2020
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

Fri, Feb 7, 2020
19:49
2018 Pan Pacific Lymphoma Conference

Cutaneous T-cell Lymphoma: Management of Transformed Mycosis Fungoides a...

Feat. Y. Kim
12:53
KU Hematology & Medical Oncology Review 2019

ASCO 2019 Non Hodgkin Lymphoma Update : Polatuzumab Vedotin for R/R DLBC...

Feat. M. Hoffmann
24:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIET an...

Feat. F. Locke
06:12
Indy Hematology Review

New Approaches in DLBCL

Feat. J. Leonard
30:08
City of Hope

Advances in Therapy in Cutaneous T Cell Lymphoma

Feat. C. Querfeld
15:41
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

PI3Ki's in Indolent Lymphoma: Overview of Approved Drugs, Trial Based Da...

Feat. A. Zelenetz
10:24
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Double-Hit Lymphoma Diagnosis, Initial and Relapsed/Refractory Treatment...

Feat. K. Dunleavy
08:39
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as Fron...

Feat. S. Ansell
07:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Plasmablastic Lymphoma: Survival Analysis of a SEER Database (2010-2016)...

Feat. J. Florindez
12:54
Craig Portell

Untreated Follicular Lymphoma - Treatment Options for Patients with Earl...

13:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Treatment of Primary CNS Lymphoma: Upfront Regimen, Surgery, Treatment o...

Feat. C. Grommes
14:46
Indy Hematology Review

Treatment of Follicular Lymphoma and Other Indolent Lymphomas: Is Target...

Feat. B. Cheson
15:50
Indy Hematology Review

Treatment Algorithm for DLBCL

Feat. J. Leonard
21:11
2018 Pan Pacific Lymphoma Conference

Use of Total Metabolic Tumor Volume in PET Scans

Feat. N. Hansen
20:51
Carla Casulo

Prognostic Markers in Follicular Lymphoma, FLIPI Score and Results of PR...

16:50
Moffitt Cancer Center

Management and Prevention of CAR-T Toxicities

Feat. B. Shah
17:49
Jonathan Friedberg

How to Improve on RCHOP for DLBCL: Role of Novel Agents

07:40
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract NHL 088: Angiogenesis’ Related Polymorphism Emerges as Pro...

Feat. A. Brito
12:35
Jonathon Cohen

Current Approaches to Evaluation and Management of Mantle Cell Lymphoma

10:46
2018 Pan Pacific Lymphoma Conference

New Approaches to Initial treatment of DLBCL: R-CHOP +

Feat. N. Bartlett